S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.59 (-1.85%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.59 (-1.85%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.59 (-1.85%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.59 (-1.85%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
Free Trial

Charles River Laboratories International (CRL) SEC Filings & 10K Form

→ The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad)
Free crl Stock Alerts
$226.06
-1.49 (-0.65%)
(As of 12:39 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Recent Charles River Laboratories International SEC Filings

Export to Excel
DateFilerForm TypeView
03/29/2024
7:00 AM		Charles River Laboratories International (Filer)
Form DEF 14A
03/29/2024
7:01 AM		Charles River Laboratories International (Filer)
Form ARS
03/25/2024
5:48 PM		Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4/A
03/25/2024
5:52 PM		Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4/A
03/25/2024
5:58 PM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4/A
03/25/2024
6:00 PM		Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4/A
03/25/2024
4:49 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4/A
03/25/2024
4:52 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4/A
03/25/2024
4:55 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4/A
03/11/2024
3:42 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
1:34 PM		Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
3:54 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
11:47 AM		Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:37 PM		Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
2:14 PM		Charles River Laboratories International (Subject)
Creamer Victoria L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
11:42 AM		Charles River Laboratories International (Subject)
Parisotto Shannon M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:57 PM		Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
10:09 AM		Barbo William D (Reporting)
Charles River Laboratories International (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
4:28 PM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:32 PM		Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:37 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
10:02 AM		Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
8:19 AM		Charles River Laboratories International (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
6:30 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
7:31 PM		Charles River Laboratories International (Issuer)
Kemps-Polanco Reshema (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:35 PM		Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:14 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:34 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4/A
01/31/2024
4:26 PM		Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:28 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:31 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:23 PM		Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:59 PM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:03 PM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
3:34 PM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
1:27 PM		BlackRock Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
01/16/2024
3:32 PM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
3:09 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:10 PM		Charles River Laboratories International (Subject)
Creamer Victoria L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:10 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
11:36 AM		Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The "Smart Money" Is Ready for May 1st Are You? (Ad)

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…
11/15/2023
8:23 AM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
7:31 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
11:14 AM		Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
8:06 AM		Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
6:30 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2023
3:23 PM		Charles River Laboratories International (Issuer)
WALLMAN RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
1:57 PM		Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
12:54 PM		Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
8:09 AM		Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2023
6:30 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
3:37 PM		BlackRock Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
07/05/2023
2:29 PM		Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
2:31 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
9:22 AM		Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
5:10 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
3:17 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
12:18 PM		Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
12:21 PM		Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
12:24 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
12:27 PM		Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
12:38 PM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
3:55 PM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
2:24 PM		Charles River Laboratories International (Issuer)
Thompson Craig B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
2:27 PM		Charles River Laboratories International (Issuer)
WILSON VIRGINIA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
1:48 PM		Charles River Laboratories International (Issuer)
REESE C RICHARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
1:26 PM		Charles River Laboratories International (Issuer)
Kochevar Deborah Turner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
1:30 PM		Charles River Laboratories International (Issuer)
Llado George Sr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
1:43 PM		Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
1:46 PM		Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
1:11 PM		Andrews Nancy C (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
1:23 PM		BERTOLINI ROBERT J (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
1:18 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
3:02 PM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
1:42 PM		Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
1:49 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
1:20 PM		Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2023
1:51 PM		Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/11/2023
8:08 AM		Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2023
6:30 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
7:00 AM		Charles River Laboratories International (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NYSE:CRL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends